ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Momentum Continues For Private Development Of Free Standing Cancer Centers

July 19, 1985

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

October 24, 1996

NIH to ban consulting by top officials, limit outside work by other employees.

June 25, 2004

First Oncology Nursing Certifications Exams Scheduled For April 30

November 8, 1985

In Brief: King Named To Replace Saunders; Zubrod Retires, Will Go To Miami; Perry acting Treatment Chief

June 14, 1974